Published in Lancet on January 11, 2000
A new method to monitor drugs at dance venues. BMJ (2001) 0.93
STRIPE: an interactive computer program for the analysis of drug pharmacokinetics. J Pharmacol Methods (1983) 4.64
Side effects of long-term amiodarone therapy. Circulation (1983) 3.03
Fatal overdosage with disopyramide. Lancet (1978) 2.96
Smoking and decreased fertilisation rates in vitro. Lancet (1992) 2.92
Fine needle aspiration cytology in the management of a parotid mass: a two centre retrospective study. Surgeon (2005) 2.77
Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol (2006) 2.49
Purchasing 'legal highs' on the Internet--is there consistency in what you get? QJM (2010) 2.43
Amiodarone pharmacokinetics. Am Heart J (1983) 2.42
Volume and outcome in hospital care: evidence, explanations and implications. Health Serv Manage Res (1990) 2.28
Comparison of two strategies for myocardial management during coronary artery operations. Ann Thorac Surg (1994) 2.21
Deaths from abuse of volatile substances: a national epidemiological study. Br Med J (Clin Res Ed) (1985) 2.19
Measuring brain natriuretic peptide. Lancet (1996) 2.03
Categorizing sex and identity from the biological motion of faces. Curr Biol (2001) 1.87
Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int (2007) 1.86
Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol (2004) 1.82
Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? J Clin Endocrinol Metab (2001) 1.78
An investigation of 140 deaths associated with volatile substance abuse in the United Kingdom (1971-1981). Hum Toxicol (1982) 1.64
Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation (2002) 1.64
Controlling deaths from volatile substance abuse in under 18s: the effects of legislation. BMJ (1992) 1.63
Minimally invasive late free flap salvage: indications, efficacy and implications for reconstructive microsurgeons. J Plast Reconstr Aesthet Surg (2011) 1.59
Evaluation of fetal arrhythmias by echocardiography. Br Heart J (1983) 1.59
Line transect methods for plant surveys. Biometrics (2007) 1.55
Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart J (2001) 1.54
Plasma nitrate concentrations in children with infectious and noninfectious diarrhea. J Pediatr Gastroenterol Nutr (2001) 1.51
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects. Aliment Pharmacol Ther (2012) 1.50
Simple bioequivalence criteria: are they relevant to critical dose drugs? Experience gained from cyclosporine. Ther Drug Monit (1997) 1.48
TGF-beta quantitation can be tricky. Transplantation (1999) 1.47
Chlortenoxicam pharmacokinetics in young and elderly human volunteers. Postgrad Med J (1988) 1.45
An introduction to the clinical toxicology of volatile substances. Drug Saf (1990) 1.40
Variation in mortality from ischaemic heart disease between England and Scotland. Q J Med (1987) 1.40
Use of ventricular stroke work index and ventricular function curves in assessing myocardial contractility. Crit Care Nurse (1995) 1.39
A controlled trial of substrate-enhanced, warm reperfusion ("hot shot") versus simple reperfusion. Ann Thorac Surg (2000) 1.38
Aspartame pharmacokinetics - the effect of ageing. Age Ageing (1996) 1.37
The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med (2009) 1.36
Influence of motion signals on the perceived position of spatial pattern. Nature (1999) 1.36
High-performance liquid chromatographic measurement of amiodarone and its desethyl metabolite: methodology and preliminary observations. Ther Drug Monit (1982) 1.31
Dial Access Library-Patient Information Service. An experiment in health education. N Engl J Med (1973) 1.30
Comparison of methods to identify individuals at increased risk of coronary disease from the general population. BMJ (2003) 1.28
SIMP: a computer program in BASIC for nonlinear curve fitting. J Pharmacol Methods (1985) 1.27
The maize An2 gene is induced by Fusarium attack and encodes an ent-copalyl diphosphate synthase. Plant Mol Biol (2005) 1.26
Rapid high-performance liquid chromatographic method for the measurement of verapamil and norverapamil in blood plasma or serum. J Chromatogr (1981) 1.26
Paediatric use of mexiletine and disopyramide. Br Med J (1979) 1.23
Amiodarone in testis and semen. Lancet (1985) 1.20
Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension (1998) 1.20
Buying 'legal' recreational drugs does not mean that you are not breaking the law. QJM (2010) 1.19
Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit (2001) 1.17
Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients. Br J Anaesth (1988) 1.14
Mental health in medical students. A case control study using the 60 item General Health Questionnaire. Scott Med J (2000) 1.13
A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition. J Neural Transm (Vienna) (2003) 1.12
Amiodarone in pregnancy. Lancet (1983) 1.11
Mobility of people with retinitis pigmentosa as a function of vision and psychological variables. Optom Vis Sci (1996) 1.10
Is circadian variation in theophylline trough serum concentrations determined by time of dosing? Br J Clin Pharmacol (1984) 1.10
PrP gene dosage and long term potentiation. Neurodegeneration (1995) 1.09
New approaches to cyclosporine monitoring raise further concerns about analytical techniques. Clin Chem (2000) 1.07
Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy. Circulation (1985) 1.07
Postmortem assay of digoxin by radioimmunoassay. J Clin Pathol (1975) 1.06
Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia (2001) 1.06
The interaction between i.v. theophylline and chronic oral dosing with slow release nifedipine in volunteers. Br J Clin Pharmacol (1986) 1.06
Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD). QJM (2008) 1.05
Determination of medifoxamine in plasma and urine by high-performance liquid chromatography. J Chromatogr (1989) 1.05
The effect of spontaneous changes in urinary pH on mexiletine plasma concentrations and excretion during chronic administration to healthy volunteers. Br J Clin Pharmacol (1979) 1.04
Clinical pharmacokinetic studies with lornoxicam. Postgrad Med J (1990) 1.02
Rapid high-performance liquid chromatographic method for the measurement of amiodarone in blood plasma or serum at the concentrations attained during therapy. J Chromatogr (1980) 1.02
Amiodarone pharmacokinetics. Br J Clin Pract Suppl (1986) 1.02
The systemic availability of a slow release rectal preparation of lignocaine [proceedings]. Br J Clin Pharmacol (1978) 1.02
Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01
Pharmacokinetics of flupirtine in elderly volunteers and in patients with moderate renal impairment. Postgrad Med J (1988) 1.01
Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J (1995) 1.01
High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in small tissue samples after enzymatic digestion. J Clin Pathol (1983) 1.00
Cardiac troponins and creatine kinase content of striated muscle in common laboratory animals. Clin Chim Acta (2001) 0.99
Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid. J Clin Oncol (1983) 0.99
Suspected solvent abuse in cases referred to the Poisons Unit, Guy's Hospital, July 1980-June 1981. Hum Toxicol (1982) 0.99
The measurement of lignocaine at low concentrations in plasma, a comparison of gas liquid chromatography with enzyme immunoassay. Br J Clin Pharmacol (1979) 0.99
Accuracy of cyclosporin measurements made in capillary blood samples obtained by skin puncture. Ther Drug Monit (2000) 0.98
Intravenous and oral amiodarone for arrhythmias in children. Br Heart J (1986) 0.98
Systemic availability of oral verapamil and effect on PR interval in man. Br J Clin Pharmacol (1981) 0.98
Lack of effect of interferon alpha 2a upon fluorouracil pharmacokinetics. Br J Cancer (1994) 0.98
The influence of urinary pH on flecainide excretion and its serum pharmacokinetics. Br J Clin Pharmacol (1984) 0.98
In vitro absorption of some o-phthalate diesters through human and rat skin. Environ Health Perspect (1987) 0.98
Limited sampling strategies for estimating cyclosporin area under the concentration-time curve: review of current algorithms. Ther Drug Monit (2001) 0.97
Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection. Clin Chem (2000) 0.97
HPLC assay with ultraviolet detection for therapeutic drug monitoring of sirolimus. Clin Chem (2001) 0.97
A multi-differential neuromorphic approach to motion detection. Int J Neural Syst (1999) 0.97
Mexiletine in human blood and breast milk. Postgrad Med J (1981) 0.97
Lack of response to intravenous calcium in severe verapamil poisoning. Lancet (1982) 0.97
Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids. Br Med J (Clin Res Ed) (1987) 0.97
Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Endocrinol (2001) 0.97
Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs. Postgrad Med J (1990) 0.97
Measurement of sirolimus in whole blood using high-performance liquid chromatography with ultraviolet detection. Clin Ther (2000) 0.97
A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res (1992) 0.96
An immunoassay for the measurement of sirolimus. Clin Ther (2000) 0.96
Mexiletine for control of ventricular dysrhythmias in pregnancy. Lancet (1980) 0.96
Variable bioavailability of oral melatonin. N Engl J Med (1997) 0.96
The United Kingdom Cyclosporin Quality Assessment Scheme. Ther Drug Monit (1986) 0.96
Visual assessment of the timing of bruising by forensic experts. J Forensic Leg Med (2010) 0.96